BioNTech SE Website

BioNTech SE

NasdaqGS-BNTX

Income Statement
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

108.6

482.3

18,976.7

17,310.6

3,819

2,690.6

Total Revenues % Chg.

—

-14.9%

344.1%

3,834.6%

-8.8%

-77.9%

-70.7%

Cost of Goods Sold, Total

17.4

59.3

2,911.5

2,995

599.8

459.8

Gross Profit

91.2

423

16,065.2

14,315.6

3,219.2

2,230.8

Selling General & Admin Expenses, Total

48.7

108.5

327.2

541.2

557.7

612.2

R&D Expenses

226.5

645

949.2

1,537

1,783.1

2,167.8

Other Operating Expenses

-2.5

-9.1

79.5

320.5

-91.2

235.4

Other Operating Expenses, Total

272.7

744.4

1,355.9

2,398.7

2,249.6

3,015.4

Operating Income

-181.5

-321.4

14,709.3

11,916.9

969.6

-784.6

Interest Expense, Total

-1.7

-2

-27.3

-18.9

-7.9

-14.9

Interest And Investment Income

1.8

1.6

1.5

48.5

357.6

357.6

Net Interest Expenses

0.1

-0.4

-25.8

29.6

349.7

342.7

Income (Loss) On Equity Invest.

—

—

—

—

—

—

Currency Exchange Gains (Loss)

2.3

-42.6

512.5

792.4

-268

-41.2

Other Non Operating Income (Expenses)

-0.3

-20.4

-277.8

216.8

162

295.7

EBT, Excl. Unusual Items

-179.4

-384.8

14,918.2

12,955.7

1,213.3

-187.4

Legal Settlements

—

—

—

—

-9

-3

-29.4

-61.8

Other Unusual Items

—

—

239

137.2

1.4

2.2

2.2

EBT, Incl. Unusual Items

-179.4

-145.8

15,046.4

12,954.1

1,186.1

-247

Income Tax Expense

-0.2

-161

4,753.9

3,519.7

255.8

257.4

Earnings From Continuing Operations

-179.2

15.2

10,292.5

9,434.4

930.3

-504.4

Minority Interest

0.1

—

—

—

—

—

Net Income

-179.1

15.2

10,292.5

9,434.4

930.3

-504.4

Net Income to Common Incl Extra Items

-179.1

15.2

10,292.5

9,434.4

930.3

-504.4

Net Income to Common Excl. Extra Items

-179.1

15.2

10,292.5

9,434.4

930.3

-504.4

Total Shares Outstanding

226.8

241.5

242.5

243.2

237.7

237.8

Weighted Avg. Shares Outstanding

211.5

235.4

244

243.3

240.6

240

Weighted Avg. Shares Outstanding Dil

211.5

248.5

259.7

249.8

242.7

240

EPS

-0.8

0.1

42.2

38.8

3.9

-2.1

EPS Diluted

-0.9

0.1

39.6

37.8

3.8

-2.1

EBITDA

-152.3

-289

14,755.5

11,981.4

1,107.8

-621.5

Effective Tax Rate

0.1%

110.4%

31.6%

27.2%

21.6%

-104.2%